Literature DB >> 17660949

Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma.

Kongthawat Chairatvit1, Chatri Ngamkitidechakul.   

Abstract

A prominent feature of all cancers including oral carcinoma is an abnormality in cellular proliferation. Neural precursor cell-expressed developmentally down-regulated 8 (NEDD8) is a ubiquitin-like protein exerting its biological function through covalent ligation to a family of cullin proteins, which act as a component of the Skp1, cullin, and F-box protein complex that plays a critical role in the regulation of cell cycle. Using Western blot analysis, an increase in NEDD8 conjugation was observed in all highly proliferative cells, including immortalized normal oral keratinocyte (NOK), oral-derived carcinoma (KB, HSC4), and several types of human carcinoma cell lines as compared to normal human gingival fibroblast. The level of NEDD8 conjugation was proportionally dependent on the concentration of serum in culture medium, which also affected proliferation status of oral squamous cell carcinoma. NEDD8 conjugation was required for proliferation of the carcinoma cell since the transfection of dominant negative Ubc12 (Ubc12C111S) could prolong the rate of proliferation. Taken together, up-regulation of the NEDD8 conjugation is an essential requirement for the enhancement of proliferation of oral carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660949     DOI: 10.1007/s11010-007-9566-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

Authors:  T Kawakami; T Chiba; T Suzuki; K Iwai; K Yamanaka; N Minato; H Suzuki; N Shimbara; Y Hidaka; F Osaka; M Omata; K Tanaka
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells.

Authors:  G Goldstein; M Scheid; U Hammerling; D H Schlesinger; H D Niall; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.

Authors:  E E Patton; A R Willems; D Sa; L Kuras; D Thomas; K L Craig; M Tyers
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

4.  Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein.

Authors:  T Kamitani; K Kito; H P Nguyen; E T Yeh
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

5.  The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.

Authors:  M Brandeis; T Hunt
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Identification of NEDD8-conjugation site in human cullin-2.

Authors:  H Wada; E T Yeh; T Kamitani
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

7.  TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.

Authors:  Kohichiroh Yasui; Shigeki Arii; Chen Zhao; Issei Imoto; Masakazu Ueda; Hisaki Nagai; Mitsuru Emi; Johji Inazawa
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

8.  Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.

Authors:  Ning Zheng; Brenda A Schulman; Langzhou Song; Julie J Miller; Philip D Jeffrey; Ping Wang; Claire Chu; Deanna M Koepp; Stephen J Elledge; Michele Pagano; Ronald C Conaway; Joan W Conaway; J Wade Harper; Nikola P Pavletich
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

9.  A new NEDD8-ligating system for cullin-4A.

Authors:  F Osaka; H Kawasaki; N Aida; M Saeki; T Chiba; S Kawashima; K Tanaka; S Kato
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

10.  Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data.

Authors:  David G Covell; Anders Wallqvist; Alfred A Rabow; Narmada Thanki
Journal:  Mol Cancer Ther       Date:  2003-03       Impact factor: 6.261

View more
  23 in total

Review 1.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

Review 2.  Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Gwénaël Rabut; Matthias Peter
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

Review 3.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

4.  Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.

Authors:  Christopher N Batuello; Paula M Hauck; Jaimie M Gendron; Jason A Lehman; Lindsey D Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

5.  The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.

Authors:  Liqun Zhao; Ping Yue; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2011-09-13       Impact factor: 6.261

6.  Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.

Authors:  Julie L Lukkarila; Sara R da Silva; Mohsin Ali; Vijay M Shahani; G Wei Xu; Judd Berman; Andrew Roughton; Sirano Dhe-Paganon; Aaron D Schimmer; Patrick T Gunning
Journal:  ACS Med Chem Lett       Date:  2011-05-16       Impact factor: 4.345

7.  De novo DNA methyltransferase DNMT3b interacts with NEDD8-modified proteins.

Authors:  Meir Shamay; Melanie Greenway; Gangling Liao; Richard F Ambinder; S Diane Hayward
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

8.  NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.

Authors:  T Hosono; T Tanaka; K Tanji; T Nakatani; T Kamitani
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

9.  Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.

Authors:  Ayumi Yamamoto; Atsushi Kasamatsu; Shunsaku Ishige; Kazuyuki Koike; Kengo Saito; Yukinao Kouzu; Hirofumi Koike; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-04       Impact factor: 4.553

10.  MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study.

Authors:  Wei-Chou Lin; Kuan-Lin Kuo; Chung-Sheng Shi; June-Tai Wu; Ju-Ton Hsieh; Hong-Chiang Chang; Shih-Ming Liao; Chien-Tso Chou; Chih-Kang Chiang; Wei-Shuo Chiu; Tzu-Yuan Chiu; Yeong-Shiau Pu; I-Lin Ho; Zuo-He Wang; Shih-Chen Chang; Shing-Hwa Liu; Yung-Ming Jeng; Kuo-How Huang
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.